A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 31/40 (2006.01) A61K 31/4025 (2006.01) A61K 31/41 (2006.01)
Patent
CA 2479222
The present invention is directed to methods for treating liver failure, loss of patency of the ductus arteriosus, glaucoma or ocular hypertension, comprising administering to the patient in need thereof a therapeutically effective amount of a selective EP4 receptor agonist of formulae (I) or (II) wherein the variables A, B, Q, =U, and R2 for Formula (I); and the variables Ar, =M, =N, R, W, and Z for Formula (II) are as defined in the specification.
L'invention concerne des méthodes de traitement de l'insuffisance cardiaque, de la perte de la perméabilité du canal artériel, du glaucome ou de l'hypertension oculaire. Ces méthodes consistent à administrer à un patient ayant besoin de ce traitement une dose thérapeutiquement efficace d'un agoniste du récepteur EP¿4? sélectif représenté par la formule (I) ou (II), dans laquelle les variables A, B, Q, =U, et R?2¿ pour la formule (I); et les variables Ar, =M, =N, R, W, et Z pour la formule (II), sont telles que définies dans le descriptif.
Cameron Kimberly O'keefe
Lefker Bruce Allen
Pfizer Products Inc.
Sim & Mcburney
LandOfFree
Use of selective ep4 receptor agonists for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of selective ep4 receptor agonists for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of selective ep4 receptor agonists for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1889177